谷歌浏览器插件
订阅小程序
在清言上使用

Two years of high-efficacy therapy reduces disease activity and brain volume loss in Japanese patients with relapse-onset multiple sclerosis

H. Yokote,Y. Miyazaki,S. Toru, Y. Nishida, T. Hattori, M. Niino,N. Sanjo, T. Yokota

MULTIPLE SCLEROSIS JOURNAL(2022)

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要